Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.9133 |
High Similarity |
NPD6234 |
Discontinued |
0.8874 |
High Similarity |
NPD4967 |
Phase 2 |
0.8874 |
High Similarity |
NPD4965 |
Approved |
0.8874 |
High Similarity |
NPD4966 |
Approved |
0.8726 |
High Similarity |
NPD7228 |
Approved |
0.8675 |
High Similarity |
NPD37 |
Approved |
0.8633 |
High Similarity |
NPD3027 |
Phase 3 |
0.8291 |
Intermediate Similarity |
NPD7199 |
Phase 2 |
0.8187 |
Intermediate Similarity |
NPD7184 |
Clinical (unspecified phase) |
0.8171 |
Intermediate Similarity |
NPD7240 |
Approved |
0.817 |
Intermediate Similarity |
NPD1653 |
Approved |
0.8108 |
Intermediate Similarity |
NPD7266 |
Discontinued |
0.8069 |
Intermediate Similarity |
NPD1613 |
Approved |
0.8069 |
Intermediate Similarity |
NPD1612 |
Clinical (unspecified phase) |
0.8058 |
Intermediate Similarity |
NPD3705 |
Approved |
0.8026 |
Intermediate Similarity |
NPD6143 |
Clinical (unspecified phase) |
0.8024 |
Intermediate Similarity |
NPD7090 |
Clinical (unspecified phase) |
0.7972 |
Intermediate Similarity |
NPD1530 |
Clinical (unspecified phase) |
0.7927 |
Intermediate Similarity |
NPD3818 |
Discontinued |
0.7917 |
Intermediate Similarity |
NPD1529 |
Clinical (unspecified phase) |
0.7871 |
Intermediate Similarity |
NPD6980 |
Clinical (unspecified phase) |
0.7812 |
Intermediate Similarity |
NPD4868 |
Clinical (unspecified phase) |
0.7784 |
Intermediate Similarity |
NPD7237 |
Clinical (unspecified phase) |
0.7765 |
Intermediate Similarity |
NPD8055 |
Clinical (unspecified phase) |
0.7725 |
Intermediate Similarity |
NPD7074 |
Phase 3 |
0.7665 |
Intermediate Similarity |
NPD7054 |
Approved |
0.7625 |
Intermediate Similarity |
NPD1934 |
Approved |
0.7619 |
Intermediate Similarity |
NPD7472 |
Approved |
0.7611 |
Intermediate Similarity |
NPD7680 |
Approved |
0.7589 |
Intermediate Similarity |
NPD1357 |
Approved |
0.7588 |
Intermediate Similarity |
NPD4338 |
Clinical (unspecified phase) |
0.7584 |
Intermediate Similarity |
NPD4060 |
Phase 1 |
0.7569 |
Intermediate Similarity |
NPD2983 |
Phase 2 |
0.7569 |
Intermediate Similarity |
NPD2982 |
Phase 2 |
0.7551 |
Intermediate Similarity |
NPD4908 |
Phase 1 |
0.7536 |
Intermediate Similarity |
NPD5283 |
Phase 1 |
0.7532 |
Intermediate Similarity |
NPD6674 |
Discontinued |
0.7529 |
Intermediate Similarity |
NPD7685 |
Pre-registration |
0.75 |
Intermediate Similarity |
NPD2981 |
Phase 2 |
0.7485 |
Intermediate Similarity |
NPD3882 |
Suspended |
0.7483 |
Intermediate Similarity |
NPD3018 |
Phase 2 |
0.7471 |
Intermediate Similarity |
NPD6797 |
Phase 2 |
0.7469 |
Intermediate Similarity |
NPD2393 |
Clinical (unspecified phase) |
0.7467 |
Intermediate Similarity |
NPD3619 |
Clinical (unspecified phase) |
0.7467 |
Intermediate Similarity |
NPD3620 |
Phase 2 |
0.745 |
Intermediate Similarity |
NPD4907 |
Clinical (unspecified phase) |
0.7448 |
Intermediate Similarity |
NPD4379 |
Clinical (unspecified phase) |
0.7431 |
Intermediate Similarity |
NPD1610 |
Phase 2 |
0.7427 |
Intermediate Similarity |
NPD7251 |
Discontinued |
0.7427 |
Intermediate Similarity |
NPD6559 |
Discontinued |
0.7423 |
Intermediate Similarity |
NPD3817 |
Phase 2 |
0.7417 |
Intermediate Similarity |
NPD230 |
Phase 1 |
0.7391 |
Intermediate Similarity |
NPD228 |
Approved |
0.7384 |
Intermediate Similarity |
NPD7808 |
Phase 3 |
0.7381 |
Intermediate Similarity |
NPD6166 |
Phase 2 |
0.7381 |
Intermediate Similarity |
NPD6167 |
Clinical (unspecified phase) |
0.7381 |
Intermediate Similarity |
NPD6168 |
Clinical (unspecified phase) |
0.7372 |
Intermediate Similarity |
NPD4110 |
Phase 3 |
0.7372 |
Intermediate Similarity |
NPD4109 |
Clinical (unspecified phase) |
0.7365 |
Intermediate Similarity |
NPD6232 |
Discontinued |
0.7365 |
Intermediate Similarity |
NPD2861 |
Phase 2 |
0.7362 |
Intermediate Similarity |
NPD2978 |
Approved |
0.7362 |
Intermediate Similarity |
NPD2801 |
Approved |
0.7362 |
Intermediate Similarity |
NPD1465 |
Phase 2 |
0.7362 |
Intermediate Similarity |
NPD2977 |
Approved |
0.7337 |
Intermediate Similarity |
NPD7473 |
Discontinued |
0.7333 |
Intermediate Similarity |
NPD7975 |
Clinical (unspecified phase) |
0.7333 |
Intermediate Similarity |
NPD6859 |
Clinical (unspecified phase) |
0.7333 |
Intermediate Similarity |
NPD4381 |
Clinical (unspecified phase) |
0.7325 |
Intermediate Similarity |
NPD6190 |
Approved |
0.731 |
Intermediate Similarity |
NPD1091 |
Approved |
0.7303 |
Intermediate Similarity |
NPD6355 |
Discontinued |
0.7267 |
Intermediate Similarity |
NPD7993 |
Clinical (unspecified phase) |
0.7256 |
Intermediate Similarity |
NPD5563 |
Clinical (unspecified phase) |
0.7251 |
Intermediate Similarity |
NPD5844 |
Phase 1 |
0.7246 |
Intermediate Similarity |
NPD3022 |
Approved |
0.7246 |
Intermediate Similarity |
NPD3021 |
Approved |
0.7222 |
Intermediate Similarity |
NPD6055 |
Clinical (unspecified phase) |
0.7215 |
Intermediate Similarity |
NPD5307 |
Clinical (unspecified phase) |
0.7212 |
Intermediate Similarity |
NPD6374 |
Clinical (unspecified phase) |
0.7211 |
Intermediate Similarity |
NPD4749 |
Approved |
0.7192 |
Intermediate Similarity |
NPD422 |
Phase 1 |
0.7179 |
Intermediate Similarity |
NPD5762 |
Approved |
0.7179 |
Intermediate Similarity |
NPD5763 |
Approved |
0.717 |
Intermediate Similarity |
NPD5058 |
Phase 3 |
0.7153 |
Intermediate Similarity |
NPD1548 |
Phase 1 |
0.7152 |
Intermediate Similarity |
NPD4628 |
Phase 3 |
0.7152 |
Intermediate Similarity |
NPD7095 |
Approved |
0.7152 |
Intermediate Similarity |
NPD8455 |
Phase 2 |
0.7143 |
Intermediate Similarity |
NPD1940 |
Clinical (unspecified phase) |
0.7143 |
Intermediate Similarity |
NPD6653 |
Approved |
0.7143 |
Intermediate Similarity |
NPD5494 |
Approved |
0.7134 |
Intermediate Similarity |
NPD970 |
Clinical (unspecified phase) |
0.7126 |
Intermediate Similarity |
NPD7075 |
Discontinued |
0.7125 |
Intermediate Similarity |
NPD1511 |
Approved |
0.7125 |
Intermediate Similarity |
NPD4357 |
Discontinued |
0.7105 |
Intermediate Similarity |
NPD7827 |
Phase 1 |
0.7105 |
Intermediate Similarity |
NPD6410 |
Clinical (unspecified phase) |
0.7097 |
Intermediate Similarity |
NPD7097 |
Phase 1 |
0.7089 |
Intermediate Similarity |
NPD1652 |
Phase 2 |
0.7086 |
Intermediate Similarity |
NPD7549 |
Discontinued |
0.7081 |
Intermediate Similarity |
NPD2532 |
Approved |
0.7081 |
Intermediate Similarity |
NPD2534 |
Approved |
0.7081 |
Intermediate Similarity |
NPD2533 |
Approved |
0.7078 |
Intermediate Similarity |
NPD5123 |
Clinical (unspecified phase) |
0.7078 |
Intermediate Similarity |
NPD5124 |
Phase 1 |
0.7073 |
Intermediate Similarity |
NPD7028 |
Phase 2 |
0.7073 |
Intermediate Similarity |
NPD4380 |
Phase 2 |
0.707 |
Intermediate Similarity |
NPD1375 |
Discontinued |
0.7067 |
Intermediate Similarity |
NPD6917 |
Clinical (unspecified phase) |
0.7059 |
Intermediate Similarity |
NPD6233 |
Phase 2 |
0.7056 |
Intermediate Similarity |
NPD7296 |
Approved |
0.7052 |
Intermediate Similarity |
NPD7804 |
Clinical (unspecified phase) |
0.7044 |
Intermediate Similarity |
NPD6398 |
Clinical (unspecified phase) |
0.7039 |
Intermediate Similarity |
NPD4625 |
Phase 3 |
0.7039 |
Intermediate Similarity |
NPD8397 |
Clinical (unspecified phase) |
0.7037 |
Intermediate Similarity |
NPD1512 |
Approved |
0.7027 |
Intermediate Similarity |
NPD1608 |
Approved |
0.7013 |
Intermediate Similarity |
NPD1558 |
Phase 1 |
0.7013 |
Intermediate Similarity |
NPD4140 |
Approved |
0.7012 |
Intermediate Similarity |
NPD4005 |
Discontinued |
0.7006 |
Intermediate Similarity |
NPD2438 |
Suspended |
0.7 |
Intermediate Similarity |
NPD8127 |
Discontinued |
0.7 |
Intermediate Similarity |
NPD2219 |
Phase 1 |
0.6993 |
Remote Similarity |
NPD6798 |
Discontinued |
0.6987 |
Remote Similarity |
NPD4978 |
Clinical (unspecified phase) |
0.6983 |
Remote Similarity |
NPD6842 |
Approved |
0.6983 |
Remote Similarity |
NPD6841 |
Approved |
0.6983 |
Remote Similarity |
NPD6843 |
Phase 3 |
0.6981 |
Remote Similarity |
NPD4236 |
Phase 3 |
0.6981 |
Remote Similarity |
NPD4237 |
Approved |
0.6975 |
Remote Similarity |
NPD7004 |
Clinical (unspecified phase) |
0.697 |
Remote Similarity |
NPD4678 |
Approved |
0.697 |
Remote Similarity |
NPD4675 |
Approved |
0.6966 |
Remote Similarity |
NPD5536 |
Phase 2 |
0.6962 |
Remote Similarity |
NPD3540 |
Phase 1 |
0.6962 |
Remote Similarity |
NPD6006 |
Clinical (unspecified phase) |
0.6962 |
Remote Similarity |
NPD6005 |
Phase 3 |
0.6962 |
Remote Similarity |
NPD6002 |
Phase 3 |
0.6962 |
Remote Similarity |
NPD6004 |
Phase 3 |
0.6962 |
Remote Similarity |
NPD6003 |
Clinical (unspecified phase) |
0.6959 |
Remote Similarity |
NPD7229 |
Phase 3 |
0.6957 |
Remote Similarity |
NPD7124 |
Phase 2 |
0.6951 |
Remote Similarity |
NPD3687 |
Approved |
0.6951 |
Remote Similarity |
NPD3686 |
Approved |
0.6946 |
Remote Similarity |
NPD7819 |
Suspended |
0.6946 |
Remote Similarity |
NPD7096 |
Clinical (unspecified phase) |
0.6944 |
Remote Similarity |
NPD7157 |
Approved |
0.6939 |
Remote Similarity |
NPD5125 |
Phase 3 |
0.6939 |
Remote Similarity |
NPD5126 |
Approved |
0.6937 |
Remote Similarity |
NPD3750 |
Approved |
0.6933 |
Remote Similarity |
NPD7314 |
Clinical (unspecified phase) |
0.6928 |
Remote Similarity |
NPD7615 |
Clinical (unspecified phase) |
0.6919 |
Remote Similarity |
NPD5242 |
Approved |
0.6914 |
Remote Similarity |
NPD6799 |
Approved |
0.6905 |
Remote Similarity |
NPD5402 |
Approved |
0.6905 |
Remote Similarity |
NPD5353 |
Approved |
0.6899 |
Remote Similarity |
NPD6099 |
Approved |
0.6899 |
Remote Similarity |
NPD2935 |
Discontinued |
0.6899 |
Remote Similarity |
NPD3539 |
Phase 1 |
0.6899 |
Remote Similarity |
NPD6100 |
Approved |
0.6894 |
Remote Similarity |
NPD5084 |
Clinical (unspecified phase) |
0.6886 |
Remote Similarity |
NPD3382 |
Approved |
0.6886 |
Remote Similarity |
NPD3384 |
Approved |
0.6886 |
Remote Similarity |
NPD3383 |
Approved |
0.6886 |
Remote Similarity |
NPD6801 |
Discontinued |
0.6879 |
Remote Similarity |
NPD6111 |
Discontinued |
0.6875 |
Remote Similarity |
NPD3060 |
Approved |
0.6875 |
Remote Similarity |
NPD5698 |
Clinical (unspecified phase) |
0.6871 |
Remote Similarity |
NPD5585 |
Approved |
0.6867 |
Remote Similarity |
NPD3600 |
Clinical (unspecified phase) |
0.6867 |
Remote Similarity |
NPD6599 |
Discontinued |
0.686 |
Remote Similarity |
NPD3787 |
Discontinued |
0.6859 |
Remote Similarity |
NPD5735 |
Approved |
0.6859 |
Remote Similarity |
NPD4340 |
Discontinued |
0.6855 |
Remote Similarity |
NPD2029 |
Clinical (unspecified phase) |
0.6853 |
Remote Similarity |
NPD7843 |
Approved |
0.6853 |
Remote Similarity |
NPD5535 |
Approved |
0.6848 |
Remote Similarity |
NPD4210 |
Discontinued |
0.6839 |
Remote Similarity |
NPD4062 |
Phase 3 |
0.6835 |
Remote Similarity |
NPD7033 |
Discontinued |
0.6835 |
Remote Similarity |
NPD5588 |
Approved |
0.6835 |
Remote Similarity |
NPD4108 |
Discontinued |
0.6832 |
Remote Similarity |
NPD6331 |
Phase 2 |
0.6832 |
Remote Similarity |
NPD8166 |
Discontinued |
0.6832 |
Remote Similarity |
NPD1878 |
Clinical (unspecified phase) |
0.6824 |
Remote Similarity |
NPD4626 |
Approved |
0.6824 |
Remote Similarity |
NPD17 |
Approved |
0.6821 |
Remote Similarity |
NPD1283 |
Approved |
0.6813 |
Remote Similarity |
NPD5958 |
Discontinued |
0.6809 |
Remote Similarity |
NPD5006 |
Approved |
0.6809 |
Remote Similarity |
NPD5005 |
Approved |
0.6809 |
Remote Similarity |
NPD2684 |
Approved |
0.6805 |
Remote Similarity |
NPD8443 |
Clinical (unspecified phase) |
0.6796 |
Remote Similarity |
NPD7243 |
Clinical (unspecified phase) |
0.6795 |
Remote Similarity |
NPD2238 |
Phase 2 |
0.6795 |
Remote Similarity |
NPD2979 |
Phase 3 |
0.6792 |
Remote Similarity |
NPD2161 |
Phase 2 |
0.6792 |
Remote Similarity |
NPD6032 |
Approved |
0.6788
|
Remote Similarity |
NPD5403 |
Approved |